Prevention of vertical transmission of hepatitis B: An observational study

Annals of Internal Medicine

Volumn 160, Issue 12, 2014, Pages 828-835

  Kubo, Ai ^a,b   Shlager, Lyle ^a,c   Marks, Amy R ^a,b   Lakritz, Dena ^a,c   Beaumont, Colette ^a,c   Gabellini, Kim ^a,c   Corley, Douglas A ^a,b  

^a OAKLAND UNIVERSITY   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TENOFOVIR;

ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INFECTION PREVENTION; INFECTION RATE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERINATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS IMMUNITY; VIRUS LOAD;

FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PERINATAL CARE; PREGNANCY; RISK FACTORS; VIRAL LOAD;

EID: 84902651610     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2529     Document Type: Article

References (19)

1. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1-31. [PMID: 16371945]
2. Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals: Perinatal Transmission. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
3. Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007;12:160-7. [PMID: 17336170]
4. Yao JL. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut. 1996;38 Suppl 2:S37-8. [PMID: 8786051] (Pubitemid 26167503)
5. Centers for Disease Control and Prevention (CDC). Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data - United States. MMWR Morb Mortal Wkly Rep. 2011;60:410-3. [PMID: 21471948]
6. Bracebridge S, Irwin D, Millership S. Prevention of perinatal hepatitis B transmission in a health authority area: an audit. Commun Dis Public Health. 2004;7:138-41. [PMID: 15259417]
7. Zhu Q, Lu Q, Gu X, Xu H, Duan S. A preliminary study on interruption of HBV transmission in uterus. Chin Med J (Engl). 1997;110:145-7. [PMID: 9594288] (Pubitemid 127510115)
8. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985;253:1740-5. [PMID: 3974052] (Pubitemid 15141106)
9. Doherty R, Garland S, Wright M, Bulotsky M, Liss C, Lakkis H, et al. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers. Pediatr Infect Dis J. 2009;28:777-81. [PMID: 19636283]
10. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preiksaitis J, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18:468-73. [PMID: 20546502]
11. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771-4. [PMID: 1113797]
12. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-10. [PMID: 1566949]
13. Smith EA, Jacques-Carroll L, Walker TY, Sirotkin B, Murphy TV. The national Perinatal Hepatitis B Prevention Program, 1994-2008. Pediatrics. 2012;129:609-16. [PMID: 22451702]
14. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332:328-36. [PMID: 16443611]
15. Centers for Disease Control and Prevention (CDC). Postvaccination serologic testing results for infants aged = 24 months exposed to hepatitis B virus at birth: United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61:768-71. [PMID: 23013723]
16. Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, et al. Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol. 2007;21 Suppl C:5C-24C. [PMID: 17568823] (Pubitemid 47162250)
17. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis. 1994;170:1418-23. [PMID: 7995980] (Pubitemid 24369900)
18. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190:489-92. [PMID: 19413519]
19. Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin Gastroenterol Hepatol. 2008;6:268-74. [PMID: 18328434] (Pubitemid 351324881)